{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:21:39Z","timestamp":1792131699559,"version":"4.4.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This article highlights biomedical research goals for the development of critical tools, including innovative diagnostics, safe and effective vaccines, and new and improved therapeutics, necessary to achieve an end to the global epidemic of sexually transmitted infections. The incidence of sexually transmitted infections (STIs), including gonorrhea, syphilis, chlamydia, and trichomoniasis, is increasing by over 1 million new cases daily and represents a global public health crisis. There is an alarming increase of gonorrhea and syphilis among men who have sex with men and bisexual men, 2 key populations also at high risk for human immunodeficiency virus. A refocused, dedicated, and intensive biomedical research program is needed targeting development of innovative diagnostics, safe and effective vaccines, and new and improved therapeutics. This article highlights biomedical research goals providing critical tools necessary to achieve an end to the global STIs epidemic.<\/jats:p>","DOI":"10.1093\/infdis\/jiz442","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T11:39:55Z","timestamp":1566992395000},"page":"1432-1434","source":"Crossref","is-referenced-by-count":39,"title":["Refocusing Research on Sexually Transmitted Infections"],"prefix":"10.1093","volume":"222","author":[{"given":"Robert W","family":"Eisinger","sequence":"first","affiliation":[{"name":"Office of the Director, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Erbelding","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S","family":"Fauci","sequence":"additional","affiliation":[{"name":"Office of the Director, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"2020110419123706200_CIT0001","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"key":"2020110419123706200_CIT0002","author":"Centers for Disease Control and Prevention"},{"key":"2020110419123706200_CIT0003","volume-title":"Global health sector strategy on sexually transmitted infections 2016\u20132021: towards ending STIs","author":"World Health Organization","year":"2016"},{"key":"2020110419123706200_CIT0004","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1136\/sextrans-2017-053192","article-title":"Performance and operational characteristics of point-of-care tests for the diagnosis of urogenital gonococcal infections","volume":"93","author":"Guy","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2020110419123706200_CIT0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1136\/sextrans-2016-053067","article-title":"Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections","volume":"93","author":"Kelly","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2020110419123706200_CIT0006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/OLQ.0000000000000572","article-title":"Point-of-care sexually transmitted infection diagnostics: proceedings of the STAR sexually transmitted infection-clinical trial group programmatic meeting","volume":"44","author":"Cristillo","year":"2017","journal-title":"Sex Transm Dis"},{"key":"2020110419123706200_CIT0007","volume-title":"Gonorrhea, chlamydia, and syphilis pipeline report","author":"Treatment Action Group","year":"2019"},{"key":"2020110419123706200_CIT0008","first-page":"S3","article-title":"A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis","volume":"93","author":"Gliddon","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2020110419123706200_CIT0009","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"2020110419123706200_CIT0010","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2015.07.015","article-title":"The potential impact of vaccination on the prevalence of gonorrhea","volume":"33","author":"Craig","year":"2015","journal-title":"Vaccine"},{"key":"2020110419123706200_CIT0011","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/OLQ.0000000000000831","article-title":"Syphilis vaccine development: requirements, challenges, and opportunities","volume":"45","author":"Cameron","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2020110419123706200_CIT0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QCO.0000000000000343","article-title":"Future prospects for new vaccines against sexually transmitted infections","volume":"30","author":"Gottlieb","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"2020110419123706200_CIT0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1074\/mcp.RA118.001125","article-title":"Quantitative proteomics of the 2016 WHO Neisseria gonorrhoeae reference strains surveys vaccine candidates and antimicrobial resistance determinants","volume":"18","author":"El-Rami","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"2020110419123706200_CIT0014","volume-title":"NIH awards will advance development of vaccines for sexually transmitted infections","author":"National Institute of Allergy and Infectious Diseases","year":"2019"},{"key":"2020110419123706200_CIT0015","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N Engl J Med"},{"key":"2020110419123706200_CIT0016","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/S2352-3018(19)30140-7","article-title":"STIs: an unintended consequence of improved sexual health?","volume":"6","author":"Scott","year":"2019","journal-title":"Lancet HIV"},{"key":"2020110419123706200_CIT0017","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2020110419123706200_CIT0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","article-title":"Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study","volume":"42","author":"Bolan","year":"2015","journal-title":"Sex Transm Dis"},{"key":"2020110419123706200_CIT0019","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz442\/30140805\/jiz442.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/9\/1432\/33828457\/jiz442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/9\/1432\/33828457\/jiz442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:59:00Z","timestamp":1604537940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/222\/9\/1432\/5564379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,9]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz442","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,1]]},"published":{"date-parts":[[2019,9,9]]}}}